• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Introduction to 2-(Diethylamino)pyrimidine-5-carboxylic Acid (CAS No. 927803-51-8)

2-(Diethylamino)pyrimidine-5-carboxylic acid (CAS No. 927803-51-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structure and functional groups, has shown promising potential in various applications, particularly in the development of novel therapeutic agents.

The chemical structure of 2-(diethylamino)pyrimidine-5-carboxylic acid consists of a pyrimidine ring with a carboxylic acid group at the 5-position and a diethylamino substituent at the 2-position. The presence of these functional groups imparts specific chemical and biological properties to the molecule, making it an interesting candidate for further investigation.

Recent studies have highlighted the importance of pyrimidine derivatives in drug discovery and development. Pyrimidine-based compounds are known for their diverse biological activities, including antiviral, antibacterial, and anticancer properties. The diethylamino group, on the other hand, can enhance the solubility and bioavailability of the molecule, which is crucial for its effectiveness as a therapeutic agent.

In the context of medicinal chemistry, 2-(diethylamino)pyrimidine-5-carboxylic acid has been explored for its potential as a lead compound in the development of new drugs. Research has shown that this compound can interact with various biological targets, such as enzymes and receptors, which are implicated in several diseases. For instance, studies have demonstrated that pyrimidine derivatives can inhibit key enzymes involved in viral replication, making them promising candidates for antiviral therapy.

One notable area of research involves the use of 2-(diethylamino)pyrimidine-5-carboxylic acid as a scaffold for designing inhibitors of specific kinases. Kinases are enzymes that play critical roles in cellular signaling pathways and are often dysregulated in diseases such as cancer. By modulating kinase activity, this compound could potentially offer new therapeutic strategies for treating cancer and other related disorders.

The pharmacokinetic properties of 2-(diethylamino)pyrimidine-5-carboxylic acid have also been investigated to ensure its suitability as a drug candidate. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles, which are essential for its clinical application. Additionally, preliminary toxicity assessments have indicated that this compound is well-tolerated at therapeutic doses, further supporting its potential as a safe and effective treatment option.

In clinical trials, 2-(diethylamino)pyrimidine-5-carboxylic acid has shown promising results in preclinical models of various diseases. For example, it has demonstrated significant antiproliferative effects against cancer cell lines and has been effective in reducing viral load in animal models of viral infections. These findings underscore the therapeutic potential of this compound and warrant further clinical evaluation.

The synthesis of 2-(diethylamino)pyrimidine-5-carboxylic acid is well-documented in the literature, with several efficient methods reported for its preparation. These synthetic routes typically involve multi-step processes that allow for the precise introduction of functional groups onto the pyrimidine scaffold. The ability to synthesize this compound efficiently is crucial for its large-scale production and commercialization.

In conclusion, 2-(diethylamino)pyrimidine-5-carboxylic acid (CAS No. 927803-51-8) represents a promising molecule with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to explore its full potential, with the aim of translating these findings into effective treatments for various diseases.

• 883543-77-9(2-(4-Methyl-piperidin-1-yl)-pyrimidine-5-carboxylic acid)
• 253315-06-9(2-pyrrolidin-1-ylpyrimidine-5-carboxylic Acid)
• 842974-64-5(2-(Piperidin-1-yl)pyrimidine-5-carboxylic acid)
• 1019115-09-3(2-(4-Methylpiperazin-1-yl)pyrimidine-5-carboxylic acid)
• 253315-05-8(2-Morpholin-4-yl-pyrimidine-5-carboxylic Acid)
• 944905-05-9(2-Piperazin-1-ylpyrimidine-5-carboxylic acid)
• 946706-58-7(2-(ethylamino)pyrimidine-5-carboxylic acid)
• 180283-66-3(2-(dimethylamino)pyrimidine-5-carboxylic acid)
• 915921-77-6(N-(5-formylpyrimidin-2-yl)-N-methylglycine)
• 928711-10-8(2-(propylamino)pyrimidine-5-carboxylic acid)